Case Reports
Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report
Affiliations
- PMID: 21510306
Item in Clipboard
Case Reports
Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report
Hepatogastroenterology.
2011 Jan-Feb.
Abstract
Sorafenib prolongs survival of patients with unresectablehepatocellular carcinoma (HCC). It is likely to be used in human immunodeficiency virus (HIV) infected patients. Interactions between sorafenib and highly active antiretroviral therapy (HAART) have not been studied yet. We report a case of serious adverse effects in anHIV-1 patient co-infected with HBV.
Similar articles
-
Drug therapy: sorafenib.Hepatology. 2010 May;51(5):1843-9. doi: 10.1002/hep.23676. Hepatology. 2010. PMID: 20432260 No abstract available.
-
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.J Clin Gastroenterol. 2009 May-Jun;43(5):489-95. doi: 10.1097/MCG.0b013e31818ddfc6. J Clin Gastroenterol. 2009. PMID: 19247201
-
Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma.Pediatr Dermatol. 2009 May-Jun;26(3):349-50. doi: 10.1111/j.1525-1470.2009.00933.x. Pediatr Dermatol. 2009. PMID: 19706105
-
Sorafenib for the treatment of unresectable hepatocellular carcinoma.Oncologist. 2009 Jan;14(1):95-100. doi: 10.1634/theoncologist.2008-0185. Epub 2009 Jan 14. Oncologist. 2009. PMID: 19144678 Review.
-
Sorafenib-induced premalignant and malignant skin lesions.Int J Dermatol. 2011 Apr;50(4):396-402. doi: 10.1111/j.1365-4632.2010.04822.x. Int J Dermatol. 2011. PMID: 21413947 Review.
Cited by
-
Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review.Drugs Aging. 2019 Apr;36(4):341-354. doi: 10.1007/s40266-019-00640-5. Drugs Aging. 2019. PMID: 30714077
-
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV.Infect Dis Rep. 2022 Jan 7;14(1):43-55. doi: 10.3390/idr14010006. Infect Dis Rep. 2022. PMID: 35076514 Free PMC article. Review.
-
Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report.Infect Agent Cancer. 2012 Jun 28;7(1):15. doi: 10.1186/1750-9378-7-15. Infect Agent Cancer. 2012. PMID: 22741810 Free PMC article.
-
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.Oncologist. 2017 May;22(5):505-e49. doi: 10.1634/theoncologist.2016-0486. Epub 2017 Mar 24. Oncologist. 2017. PMID: 28341759 Free PMC article. Clinical Trial.
-
Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.World J Gastroenterol. 2014 Oct 28;20(40):14598-614. doi: 10.3748/wjg.v20.i40.14598. World J Gastroenterol. 2014. PMID: 25356024 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical